SXTP 60 Degrees Pharmaceuticals, Inc.

NASDAQ
$1.06

60 Degrees Pharmaceuticals, Inc. (SXTP) Institutional Ownership

What the institutions did with SXTP last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
11
filed a 13F this quarter
Managers holding
8
+0 on the quarter
Buyers
4
3 opened new
Sellers
6
3 sold out entirely
Buyer share
40.0%
of managers who traded it
Breadth
-20.0
net buyers, as a share of those trading

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
Kathmere Capital Management, LLC 265.1K 75.9%
CITADEL ADVISORS LLC 22.4K 6.4%
XTX Topco Ltd 17.6K 5.0%
Kovack Advisors, Inc. 15.0K 4.3%
GEODE CAPITAL MANAGEMENT, LLC 14.6K 4.2%
UBS Group AG 13.6K 3.9%
BARCLAYS PLC 1.1K 0.3%
OSAIC HOLDINGS, INC. 25 0.0%

Largest changes

Manager Action Previous Current Change
Kathmere Capital Management, LLC Increased 144.7K 265.1K +120.4K
CITADEL ADVISORS LLC New 0 22.4K +22.4K
UBS Group AG Reduced 31.4K 13.6K -17.8K
XTX Topco Ltd New 0 17.6K +17.6K
Kovack Advisors, Inc. New 0 15.0K +15.0K
GEODE CAPITAL MANAGEMENT, LLC Reduced 16.3K 14.6K -1.7K
BARCLAYS PLC Reduced 1.9K 1.1K -804
NewEdge Advisors, LLC Sold Out 50 0 -50
TWIN PEAKS WEALTH ADVISORS, LLC Sold Out 8 0 -8
CITIGROUP INC Sold Out 1 0 -1

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.